Over-the-counter (OTC) Drugs Market - Segmented By Products (Cough, Cold, and Flu Products, Analgesics, etc.,), Distribution Channel, Geography - Growth, Trends, and Forecast (2018 - 2023)

  • ID: 4520142
  • Report
  • 142 pages
  • Mordor Intelligence
until Dec 31st 2018
1 of 5


  • Bayer AG
  • Boehringer Ingelheim
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Novartis International AG
  • Pfizer,Inc.
  • MORE
The OTC drug market was valued at USD 132.79 billion in 2017, is expected to register a CAGR of about 6.5% during the forecast period, 2018-2023. OTC medications don’t need a doctor’s prescription. This convenience of the consumer enables the direct purchase of medicine and is the prime driving force accelerating the growth of the OTC drug markets across the world. Moreover, certain factors have been instrumental in the growth of the OTC drugs market the last 10-15 years. Companies such as Pfizer, Johnson & Johnson, Sanofi, GSK and others, have increased their focus on OTC drug development to benefit from this promising market.

Product Innovation Drives the Over the Counter (OTC) Drugs Market

The OTC drug market is highly competitive, but despite the limited number of active ingredients in the market, there is a huge innovation in terms of drugs, which are resulting in improving the performance, in terms of drugs forms, dosages, and usage. Many of the major players are also investing in research for the development of new formulas to cure minor ailments and potentially get the approval for more active ingredients in OTC drugs. There is large diversification of the products, which is targeting different age groups like children, adults, women, and old people with different new products, and is driving the OTC drugs market.The other factors include high penetration in emerging markets, favorable regulatory framework, and inclination of pharmaceutical companies to switch from Rx to OTC drugs.

A probability of Substance Abuse Acts as a Major Barrier for the OTC Drug Market

Drug abuse is the major challenge to the OTC drug market, mostly by teenagers. As these drugs are readily available in the market, they are more prone to get abused on a large scale. It is projected that nearly one in every eight or nearly 12% of teenagers abuse OTC cough syrups. Over three million adolescents and youngsters are engaged in OTC drug abuse. It is an alarming statistic for the OTC market, which is hindering growth.Other factors like lack of awareness among the rural regions are also acting as a major restraint for the growth of the OTC market.

Market Segmentation Insights for the OTC Drug Market

The market is segmented by product type which includes the likes of a cough, cold and flu products, analgesics, dermatology products, gastrointestinal products, vitamins, minerals and supplementary products, ophthalmic products, sleep aids, weight loss, and other products. Vitamins, minerals and supplementary products account for the largest market size in 2017 projecting a CAGR of 5.11% over the forecast period. However, Weight Loss/Dietary Products are expected to record the highest growth at a rate of 6.05% over the forecast period. Also, Other OTC products such as ear drops, Antidiarrheal, oral antiseptics are some of the major contributors to the OTC drugs market. These are commonly and widely used products in any region of the world.

By distribution channel segment, retail pharmacies have the largest share as OTC medicines are conveniently sold in a number of retail outlets, including those without pharmacies, and are available when consumers need them. Online pharmacies segment is expected to witness a high CAGR of 8.11% over the forecast period.

Europe is expected to have High Growth Opportunities in OTC Drugs Market

Europe is the lucrative region in the global OTC drugs market. The demand in the European countries is increasing due to growing consumer appetite for self-medication. In the United Kingdom, the Government and other players are progressively shifting toward OTC drugs, as a way of reducing their rapidly increasing expenditures on prescription drugs. It is witnessed that Rx-to-OTC swapping is a strong driving factor for the market. The United Kingdom OTC market is vastly fragmented. With a large number of players into specialized manufacturing. It is calculated that the top four players have a 35% share of the total market by value in this region. The top four players include; Reckitt Benckiser Group plc, J&J, Bayer AG, Glaxo Smith Kline Plc.

Key Developments in the Market
  • February 2017- Sanofi announced that the United States Food and Drug Administration (FDA) has approved Xyzal Allergy 24HR as an over-the-counter (OTC) treatment for the relief of symptoms associated with seasonal and year-round allergies.
  • February 2017- Sanofi agreed to sell some over-the-counter (OTC) products to Ipsen SA.
Market Players - Johnson & Johnson, Novartis International AG, Bayer, Sanofi S.A., Pfizer, GlaxoSmithKline PLC, Boehringer Ingelheim, PGT Healthcare, and Takeda, among others.

Reasons to Purchase the Report
  • Follow the current and over the counter drugs market in the developed and emerging markets.
  • Examining the various perspectives of the market with the help of Porter’s Five Forces Analysis.
  • Identify the segment that is expected to dominate the market.
  • Identify the regions that are expected to witness the fastest growth during the forecast period.
  • Identify the latest developments, market shares, and strategies employed by the major market players.
  • 3 months analyst support along with the Market Estimate sheet (in Excel).
Customization of Over-the-counter (OTC) Drugs Market Report
  • This report can be customized to meet your requirements. Please connect with our Customer Service team, who will ensure you get a report that suits your needs.
Note: Product cover images may vary from those shown
2 of 5


  • Bayer AG
  • Boehringer Ingelheim
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Novartis International AG
  • Pfizer,Inc.
  • MORE
1. Introduction
1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Over-the-counter (OTC) Drugs Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Drivers
6.1.1 Product Innovation
6.1.2 High Penetration in Emerging Markets
6.1.3 Favorable Regulatory Framework
6.1.4 Inclination of Pharmaceutical Companies to Switch from Rx to OTC Drugs
6.2 Restraints
6.2.1 Probability of Substance Abuse
6.2.2 Lack of Awareness Among the Rural Regions
6.3 Opportunities
6.4 Key Challenges

7. Market Segmentation
7.1 By Products
7.1.1 Cough, Cold, and Flu Products
7.1.2 Analgesics
7.1.3 Dermatology Products
7.1.4 Gastrointestinal Products
7.1.5 Vitamins, Mineral, and Supplements (VMS)
7.1.6 Weight Loss/Dietary Products
7.1.7 Ophthalmic Products
7.1.8 Sleeping Aids
7.1.9 Others
7.2 By Distribution Channel
7.2.1 Hospital Pharmacies
7.2.2 Retail Pharmacies
7.2.3 Online Pharmacy
7.2.4 Others
7.3 By Geography
7.3.1 North America Over-the-counter (OTC) Drugs Market (2018 - 2023) United States Over-the-counter (OTC) Drugs Market (2018 - 2023) Canada Over-the-counter (OTC) Drugs Market (2018 - 2023) Mexico Over-the-counter (OTC) Drugs Market (2018 - 2023) Rest of North America
7.3.2 Europe Over-the-counter (OTC) Drugs Market (2018 - 2023) France Over-the-counter (OTC) Drugs Market (2018 - 2023) Germany Over-the-counter (OTC) Drugs Market (2018 - 2023) United Kingdom Over-the-counter (OTC) Drugs Market (2018 - 2023) Italy Over-the-counter (OTC) Drugs Market (2018 - 2023) Spain Over-the-counter (OTC) Drugs Market (2018 - 2023) Rest of Europe
7.3.3 Asia-Pacific Over-the-counter (OTC) Drugs Market (2018 - 2023) China Over-the-counter (OTC) Drugs Market (2018 - 2023) Japan Over-the-counter (OTC) Drugs Market (2018 - 2023) India Over-the-counter (OTC) Drugs Market (2018 - 2023) Australia & New Zealand Over-the-counter (OTC) Drugs Market (2018 - 2023) South Korea Over-the-counter (OTC) Drugs Market (2018 - 2023) Rest of Asia-Pacific
7.3.4 Middle East & Africa Over-the-counter (OTC) Drugs Market (2018 - 2023) GCC Over-the-counter (OTC) Drugs Market (2018 - 2023) South Africa Over-the-counter (OTC) Drugs Market (2018 - 2023) Rest of the Middle East & Africa
7.3.5 South America Over-the-counter (OTC) Drugs Market (2018 - 2023) Brazil Over-the-counter (OTC) Drugs Market (2018 - 2023) Argentina Over-the-counter (OTC) Drugs Market (2018 - 2023) Rest of South America

8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches

9. Major Players
9.1 Bayer AG
9.2 Boehringer Ingelheim
9.3 GlaxoSmithKline PLC
9.4 Johnson & Johnson
9.5 Novartis International AG
9.6 Pfizer,Inc.
9.7 PGT healthcare
9.8 Sanofi S.A
9.9 Takeda

*List not Exhaustive

10. Future of the Market

11. Disclaimer
Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Bayer AG
  • Boehringer Ingelheim
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Novartis International AG
  • Pfizer,Inc.
  • PGT healthcare
  • Sanofi S.A
  • Takeda
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown